United States · 
What does Domain Associates invest in?
Domain Associates invests most often at Series B and Series C (57% of the rounds on record), in sectors such as Tech-enabled Health, Connected-health and Longevity.
Domain Associates highlights
- 01
182 rounds on record
- 02
Mostly Series B and Series C: 57% of its rounds
- 03
Sole investor in 5 rounds, median $2.0M
- 04
24 exits from the portfolio
What they do
INVESTMENT ADVISORS TO THE FIRST VC FUND DEDICATED TO BIOTECHFrom their own website
- Type
- VC firm (from a list, unverified)
- Cheque size
- Up to $5.0M as they say
- Stages
- SeedSeries ASeries BGrowthPre-IPO
- Sectors
- Tech-enabled HealthConnected-healthLongevity
- Based in
- San Diego, United States
- Cold pitches
- Not accepted
The record
Every round we can evidence, newest first182 appearances
- 2019
5 rounds
- Dec
- Dec
- Nov
- Nov
- Feb
- 2018
1 round
- Jun
- 2017
1 round
- May
- 2016
1 round
- Dec
- 2015
7 rounds
- Nov
- Aug
- Jul
- Jun
- Jun
- Jan
- Jan
- 2014
13 rounds
- Nov
- Nov
- Oct
- Sept
- Sept
- Sept
- Jul
- Jul
- Jun
- Apr
- Apr
- Feb
- Jan
- 2013
21 rounds
- Dec
- Dec
- Nov
- Oct
- Oct
- Sept
- Aug
- Aug
- Jul
- Jul
- Jul
- Jun
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
The team
Named by the firm itself, on a filing, its Form ADV or its company registration8 named
BHBrian H. DoveyExecutive OfficeriFiling they signed
BKBrian Keith HalakExecutive OfficeriFiling they signed
JCJames Carroll BlairExecutive OfficeriFiling they signed
JIJesse I. TreuExecutive OfficeriFiling they signed
KKKathleen K. SchoemakerExecutive OfficeriFiling they signed
KPKim Puloma KamdarExecutive OfficeriFiling they signed
N(Nicole (nmn) VitulloManaging Member/Chief Compliance OfficeriForm ADV
NKNimesh K. ShahExecutive OfficeriFiling they signed
We also hold 17 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.
What the register says
From the firm's own filings with the SEC, which it must file accurately by law
$117Mgross assets of its fundsOct 2026
Exemptreporting adviserventure or small private funds
- Legal name
- Domain Associates, LLC
- SEC number
- CRD 159846
Exits from the portfolio
Companies it backed that were later bought or listed24 in all
Meritage PharmaBought by Shire$245MFeb 2015
Ariosa Diagnostics, Inc.Bought by Roche$625MDec 2014
CellBiosciencesBought by Bio-TechneUndisclosedJun 2014
SantarusBought by Salix Pharmaceuticals$2.6BNov 2013
Five Prime TherapeuticsListedUndisclosedJul 2013
Somaxon PharmaceuticalsBought by Pernix TherapeuticsUndisclosedMar 2013
SkinMedicaBought by AllerganUndisclosedNov 2012
Clovis OncologyListed$130MNov 2011
GenVaultBought by IntegenXUndisclosedFeb 2011
ZogenixListedUndisclosedNov 2010
Immune ControlBought by Corridor PharmaceuticalsUndisclosedJun 2010
Alimera SciencesListedUndisclosedApr 2010
BiPar SciencesBought by Sanofi Aventis$500MApr 2009
Tandem Diabetes CareListed$138MNov 2008
Vascular ArchitectsBought by LeMaitre VascularUndisclosedSept 2007
NovaCardiaBought by Merck & Co.$366MSept 2007
Orexigen TherapeuticsListedUndisclosedJul 2007
The latest 20 here. An exit counts when it came after the firm's first round in the company. From historical deal records.